{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:18:02Z","timestamp":1790309882971,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100022420","name":"Penland School of Craft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022420","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajt.2025.10.009","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:21:43Z","timestamp":1761146503000},"page":"621-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recurrent primary biliary cholangitis after liver transplantation: A global meta-analysis of epidemiology and risk factors"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9049-0996","authenticated-orcid":false,"given":"Pedro Robson Costa","family":"Passos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valbert Oliveira Costa","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Macambira","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohanna Idsabella","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8698-8737","authenticated-orcid":false,"given":"Isabelle Castro","family":"Vitor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Ramos","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellgner Fernandes Oliveira","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8679-382X","authenticated-orcid":false,"given":"Igor Boechat","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2578-5775","authenticated-orcid":false,"given":"Marina de Assis Bezerra Cavalcanti","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6633-9133","authenticated-orcid":false,"given":"Rodrigo Vieira","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Grossi Lopes","family":"Can\u00e7ado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/HEP.0000000000001166","article-title":"Primary biliary cholangitis: personalizing second-line therapies","volume":"82","author":"Levy","year":"2025","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.009_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/apt.15060","article-title":"Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades","volume":"49","author":"Harms","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.ajt.2025.10.009_bib3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2024.05.010","article-title":"Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation","volume":"81","author":"Montano-Loza","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.009_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2020.12.005","article-title":"Risk factors for recurrent primary biliary cirrhosis after liver transplantation: a systematic review and meta-analysis","volume":"53","author":"Li","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajt.2025.10.009_bib8","series-title":"Chapter 5: Systematic reviews of prevalence and incidence","author":"Munn","year":"2020"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/hepr.13476","article-title":"Use of Nakanuma staging and cytokeratin 7 staining for diagnosing recurrent primary biliary cholangitis after living-donor liver transplantation","volume":"50","author":"Yamashiki","year":"2020","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/s12889-019-6820-3","article-title":"Calculating incidence rates and prevalence proportions: not as simple as it seems","volume":"19","author":"Spronk","year":"2019","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/EDE.0000000000001544","article-title":"An alternative perspective on the robust Poisson method for estimating risk or prevalence ratios","volume":"34","author":"Talbot","year":"2023","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"10.1016\/j.ajt.2025.10.009_bib13","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jrsm.1521","article-title":"Synthesis of evidence from zero-events studies: A comparison of one-stage framework methods","volume":"13","author":"Xu","year":"2022","journal-title":"Res Synth Methods"},{"issue":"5","key":"10.1016\/j.ajt.2025.10.009_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/EDE.0000000000001232","article-title":"Meta-analysis of proportions using generalized linear mixed models","volume":"31","author":"Lin","year":"2020","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajt.2025.10.009_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jclinepi.2017.10.006","article-title":"Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis","volume":"93","author":"Lacny","year":"2018","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.ajt.2025.10.009_bib18","series-title":"rms: Regression Modeling Strategies. CRAN: Contributed Packages","author":"Harrell","year":"2009"},{"key":"10.1016\/j.ajt.2025.10.009_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2023.1283705","article-title":"Greedy knot selection algorithm for restricted cubic spline regression","volume":"3","author":"Arnes","year":"2023","journal-title":"Front Epidemiol"},{"key":"10.1016\/j.ajt.2025.10.009_bib20","series-title":"metafor: Meta-Analysis Package for R. CRAN: Contributed Packages","author":"Viechtbauer","year":"2009"},{"key":"10.1016\/j.ajt.2025.10.009_bib21","author":"Phillips"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.ajt.2025.10.009_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ajt.2025.10.009_bib24","author":"Deeks"},{"issue":"10","key":"10.1016\/j.ajt.2025.10.009_bib25","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/00007890-199805270-00008","article-title":"Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation","volume":"65","author":"Sebagh","year":"1998","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.009_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.transproceed.2013.11.123","article-title":"Potential benefit of mixed lymphocyte reaction assay-based immune monitoring after living donor liver transplantation for recipients with autoimmune hepatitis","volume":"46","author":"Sakai","year":"2014","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ajt.12132","article-title":"Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Carbone","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.12027","article-title":"Liver transplantation for overlap syndromes of autoimmune liver diseases","volume":"33","author":"Bhanji","year":"2013","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1432-2277.2011.01336.x","article-title":"Long-term outcome of living donor liver transplantation for primary biliary cirrhosis","volume":"25","author":"Kaneko","year":"2012","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.ajt.2025.10.009_bib31","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.transproceed.2008.10.095","article-title":"Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal","volume":"41","author":"Campsen","year":"2009","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.ajt.2025.10.009_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1872-034X.2008.00483.x","article-title":"Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: a blind histologic study","volume":"39","author":"Hytiroglou","year":"2009","journal-title":"Hepatol Res"},{"issue":"9","key":"10.1016\/j.ajt.2025.10.009_bib33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.10.009_bib36","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.ajt.2025.10.009_bib37","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1432-2277.2005.00129.x","article-title":"Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center","volume":"18","author":"Hasegawa","year":"2005","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0041-1345(03)00064-2","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"35","author":"Salguero","year":"2003","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib40","first-page":"195","article-title":"Graft and systemic disease in long-term survivors of liver transplantation","volume":"25","author":"Slapak","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.009_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression","volume":"24","author":"Dmitrewski","year":"1996","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00000478-199502000-00008","article-title":"Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation","volume":"19","author":"Pappo","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajt.2025.10.009_bib43","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9563","article-title":"The long-term outcomes of deceased-donor liver transplantation for primary biliary cirrhosis: a two-center study in China","volume":"8","author":"Chen","year":"2020","journal-title":"PeerJ"},{"issue":"11","key":"10.1016\/j.ajt.2025.10.009_bib44","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiology.220.2.r01au36329","article-title":"Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients","volume":"220","author":"Blachar","year":"2001","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.ajt.2025.10.009_bib46","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00007890-200104270-00016","article-title":"Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus","volume":"71","author":"Jain","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00007890-199701270-00012","article-title":"Weaning of immunosuppression in liver transplant recipients","volume":"63","author":"Mazariegos","year":"1997","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib48","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.transproceed.2023.03.046","article-title":"Zero mortality in living-donor liver transplantation for primary biliary cholangitis in patients with a meld score of <20","volume":"55","author":"Yanagaki","year":"2023","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.009_bib49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.hbpd.2018.01.001","article-title":"Clinical analysis of liver transplantation in autoimmune liver diseases","volume":"17","author":"Zhong","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"5","key":"10.1016\/j.ajt.2025.10.009_bib51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep4.1037","article-title":"Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: a Japanese multicenter retrospective study","volume":"1","author":"Kogiso","year":"2017","journal-title":"Hepatol Commun"},{"issue":"12","key":"10.1016\/j.ajt.2025.10.009_bib52","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/ajt.13828","article-title":"First-degree living-related donor liver transplantation in autoimmune liver diseases","volume":"16","author":"Aravinthan","year":"2016","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib53","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2025.10.009_bib54","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.ajt.2025.10.009_bib55","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.ajt.2025.10.009_bib56","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00268-001-0213-2","article-title":"Liver transplantation for nonviral, nonmalignant diseases: problem of recurrence","volume":"26","author":"Renz","year":"2002","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib59","first-page":"104","article-title":"Donor influence on outcome in patients undergoing liver transplant for primary biliary cirrhosis","volume":"8","author":"Jacob","year":"2010","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1665-2681(19)31659-X","article-title":"Anti-parietal cell autoantibodies (PCA) in primary biliary cirrhosis: a putative marker for recurrence after orthotopic liver transplantation?","volume":"9","author":"Ciesek","year":"2010","journal-title":"Ann Hepatol"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib61","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0168-8278(05)80497-0","article-title":"Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors","volume":"20","author":"Gouw","year":"1994","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.009_bib62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0016-5085(89)90643-4","article-title":"Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies","volume":"97","author":"Polson","year":"1989","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-8278(98)80220-1","article-title":"Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation","volume":"28","author":"Dubel","year":"1998","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib64","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"issue":"50","key":"10.1016\/j.ajt.2025.10.009_bib65","first-page":"322","article-title":"Recurrence of primary biliary cirrhosis after orthotopic liver transplantation","volume":"50","author":"Kurdow","year":"2003","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1440-1746.2002.02632.x","article-title":"Disease recurrence after liver transplantation in Western Australia","volume":"17","author":"Yusoff","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ajt.2025.10.009_bib68","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.1840180617","article-title":"Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation","volume":"18","author":"Balan","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","article-title":"Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation","volume":"18","author":"Hubscher","year":"1993","journal-title":"J Hepatol"},{"issue":"5 Pt 1","key":"10.1016\/j.ajt.2025.10.009_bib70","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0016-5085(88)90014-5","article-title":"Transplantation for primary biliary cirrhosis","volume":"94","author":"Esquivel","year":"1988","journal-title":"Gastroenterology"},{"issue":"suppl 3","key":"10.1016\/j.ajt.2025.10.009_bib71","first-page":"S463","article-title":"Histological recurrence of autoimmune liver diseases after living-donor liver transplantation","volume":"37","author":"Haga","year":"2007","journal-title":"Hepatol Res"},{"issue":"suppl 3","key":"10.1016\/j.ajt.2025.10.009_bib72","first-page":"S455","article-title":"Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis","volume":"37","author":"Hashimoto","year":"2007","journal-title":"Hepatol Res"},{"issue":"suppl 3","key":"10.1016\/j.ajt.2025.10.009_bib73","first-page":"S449","article-title":"Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation in Japan","volume":"37","author":"Yamagiwa","year":"2007","journal-title":"Hepatol Res"},{"issue":"7","key":"10.1016\/j.ajt.2025.10.009_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000693","article-title":"Outcomes of liver transplant recipients with autoimmune liver disease using long-term dual immunosuppression regimen without corticosteroid","volume":"3","author":"Satapathy","year":"2017","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.009_bib75","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004230050201","article-title":"Primary liver disease as a determinant for acute rejection after liver transplantation","volume":"384","author":"Seiler","year":"1999","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"10.1016\/j.ajt.2025.10.009_bib76","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1440-1746.1991.tb00909.x","article-title":"Transplantation in primary biliary cirrhosis","volume":"6","author":"Sallie","year":"1991","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib77","first-page":"57","article-title":"The results of the histological examination of the liver in the post-transplantation period","volume":"11","author":"Ilyassova","year":"2017","journal-title":"New Armen Med J"},{"issue":"suppl 1","key":"10.1016\/j.ajt.2025.10.009_bib78","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1111\/j.1432-2277.1996.tb01586.x","article-title":"Clinical significance of recurrent primary biliary cirrhosis after liver transplantation","volume":"9","author":"Knoop","year":"1996","journal-title":"Transpl Int"},{"key":"10.1016\/j.ajt.2025.10.009_bib79","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2024"},{"issue":"6","key":"10.1016\/j.ajt.2025.10.009_bib80","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jgh.15329","article-title":"Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis","volume":"36","author":"Lv","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.ajt.2025.10.009_bib81","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajt.2025.10.009_bib82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ajt.2025.10.009_bib83","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","volume":"390","author":"Kowdley","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12874-021-01381-z","article-title":"Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence","volume":"21","author":"Barker","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajt.2025.10.009_bib85","article-title":"Pretransplant evaluation and liver transplantation outcome in PBC patients","volume":"2022","author":"Mijic","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"10457","key":"10.1016\/j.ajt.2025.10.009_bib86","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis","volume":"404","author":"Tanaka","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ajt.2025.10.009_bib87","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.cgh.2021.01.029","article-title":"The epidemiology of UK autoimmune liver disease varies with geographic latitude","volume":"19","author":"Webb","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ajt.2025.10.009_bib88","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/hepr.13910","article-title":"Characteristic geoepidemiology of primary biliary cholangitis in Taiwan: a nationwide population-based study","volume":"53","author":"Cheng","year":"2023","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib89","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/LVT.0000000000000278","article-title":"Autoimmune hepatitis recurrence after liver transplantation: \u201cLes jeux sont faits.\u201d","volume":"30","author":"Chouik","year":"2024","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ajt.2025.10.009_bib90","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3389\/fimmu.2018.02309","article-title":"Comparative analysis of B-cell receptor repertoires induced by live yellow fever vaccine in young and middle-age donors","volume":"9","author":"Davydov","year":"2018","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.ajt.2025.10.009_bib91","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMra2200923","article-title":"Liver transplantation","volume":"389","author":"Lucey","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib92","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0039-1688443","article-title":"Immunosuppressive drug levels in liver transplant recipients: impact in decision making","volume":"39","author":"Kourkoumpetis","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"11","key":"10.1016\/j.ajt.2025.10.009_bib93","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1097\/TP.0000000000004209","article-title":"Recipient and center factors associated with immunosuppression practice beyond the first year after liver transplantation and impact on outcomes","volume":"106","author":"Bittermann","year":"2022","journal-title":"Transplantation"},{"issue":"5 Pt 2","key":"10.1016\/j.ajt.2025.10.009_bib94","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994-2004","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.10.009_bib95","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ajt.2025.10.009_bib96","first-page":"CD007606","article-title":"Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients","volume":"4","author":"Fairfield","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"31","key":"10.1016\/j.ajt.2025.10.009_bib97","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.3748\/wjg.v20.i31.10703","article-title":"Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review","volume":"20","author":"Sgourakis","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajt.2025.10.009_bib98","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25935","article-title":"Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.ajt.2025.10.009_bib99","article-title":"Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR study","volume":"6","author":"van Hooff","year":"2024","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.ajt.2025.10.009_bib100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ajt.2024.10.010","article-title":"Comparison of cyclosporine and tacrolimus after liver transplantation for primary biliary cholangitis: a propensity score-matched intention-to-treat registry study","volume":"25","author":"\u00c5berg","year":"2025","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525030564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525030564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:35:11Z","timestamp":1778621711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525030564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1600613525030564"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.10.009","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent primary biliary cholangitis after liver transplantation: A global meta-analysis of epidemiology and risk factors","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}